Dupuytren's contracture and drugs of ingredients of celecoxib - a phase IV clinical study of FDA data
Dupuytren's contracture is reported only by a few people who take drugs with ingredients of celecoxib. This phase IV clinical study analyzes 165,532 people who have side effects while taking drugs with ingredients of celecoxib from the the FDA. Among them, 5 have Dupuytren's contracture. Find out below who they are, when they have Dupuytren's contracture and more.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Celebrex, Celecoxib, Elyxyb.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
165,532 people reported to have side effects when taking drugs with ingredients of celecoxib.
Among them, 5 people (0.0%) have Dupuytren's contracture
What is Dupuytren's contracture?
Dupuytren's contracture (thickening of the fibrous tissue layer underneath the skin of the palm and fingers) is found to be associated with 459 drugs and 212 conditions by eHealthMe.
Number of reports submitted per year:
Time on drugs with ingredients of celecoxib when people have Dupuytren's contracture *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 100 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Dupuytren's contracture when taking drugs with ingredients of celecoxib *:
- female: 40 %
- male: 60 %
Age of people who have Dupuytren's contracture when taking drugs with ingredients of celecoxib *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Conditions people have *:
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 40.00%
- Vitamin B12 Deficiency: 1 person, 20.00%
- Rickets (softening of bones): 1 person, 20.00%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 20.00%
- Psoriasis (immune-mediated disease that affects the skin): 1 person, 20.00%
- Osteoporotic Fracture (fracture due to weak bone): 1 person, 20.00%
- Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 1 person, 20.00%
- Joint Pain: 1 person, 20.00%
- High Blood Pressure: 1 person, 20.00%
- Back Pain: 1 person, 20.00%
Other drugs people take *:
- Zocor: 2 people, 40.00%
- Norvasc: 2 people, 40.00%
- Avapro: 2 people, 40.00%
- Actonel: 2 people, 40.00%
- Xiaflex: 1 person, 20.00%
- Vioxx: 1 person, 20.00%
- Thiamine Hydrochloride: 1 person, 20.00%
- Relafen: 1 person, 20.00%
- Oruvail: 1 person, 20.00%
- Micardis: 1 person, 20.00%
Other side effects people have besides Dupuytren's contracture *:
- Hypersensitivity: 2 people, 40.00%
- Heart Rate Decreased: 2 people, 40.00%
- Purpura (purplish discoloration of the skin): 2 people, 40.00%
- High Blood Pressure: 2 people, 40.00%
- Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs): 1 person, 20.00%
- Hepatic Steatosis (fatty liver disease): 1 person, 20.00%
- Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 1 person, 20.00%
- Chest Pain: 1 person, 20.00%
- Head Injury: 1 person, 20.00%
- Haemoglobin Decreased: 1 person, 20.00%
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drugs with ingredients of celecoxib, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on celecoxib. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Detrol and Polysubstance Abuse - 2 seconds ago
- Oxycontin and Spinal Fracture - 2 seconds ago
- Mavik and Pregabalin drug interaction - 6 seconds ago
- Timoptic and Cholecystitis Acute - 9 seconds ago
- Renova and Rocaltrol drug interaction - 16 seconds ago
- Xolair and Eye Swelling - 17 seconds ago
- Cardizem Cd and Uterine Fibroids - 18 seconds ago
- Erbitux and Apnoeic Attack - 20 seconds ago
- Dopamine Hydrochloride and Voriconazole drug interaction - 22 seconds ago
- Maxidex and Partial Seizures - 24 seconds ago